GENEVA, Oct. 30 -- IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC. filed a patent application (CN2026/092711) for “COMBINATION THERAPY TARGETING CD47, PD-L1 AND VEGF”. With publication no. WO/2026/223778, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 19/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....